Siren (SIREN) has surged 22.7% in 24 hours to hit a new all-time high of $0.90, accompanied by a 340% volume increase. Our analysis examines the on-chain metricsSiren (SIREN) has surged 22.7% in 24 hours to hit a new all-time high of $0.90, accompanied by a 340% volume increase. Our analysis examines the on-chain metrics

Siren (SIREN) Rockets 22.7% as Volume Surges 340% – What the Data Reveals

For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Siren (SIREN) reached a new all-time high of $0.90166 on March 18, 2026, marking a 22.7% surge in 24 hours that propelled its market capitalization past $655 million. What catches our attention isn’t just the price action—it’s the confluence of volume dynamics, supply mechanics, and market positioning that suggests this rally may have more substance than typical altcoin pumps.

We’ve analyzed the on-chain data, trading patterns, and comparative metrics to understand whether SIREN’s momentum represents sustainable growth or a temporary speculative frenzy. The answer lies in the details.

Volume Surge and Market Cap Dynamics Point to Institutional Interest

The most striking metric in SIREN’s current rally is the trading volume spike. At $29.38 million in 24-hour volume, we’re observing a volume-to-market-cap ratio of approximately 4.48%—significantly above the 2-3% threshold that typically indicates organic institutional accumulation rather than retail FOMO.

Our analysis shows that SIREN’s market cap increased by $119.76 million (22.3%) in lockstep with the price movement, suggesting genuine capital inflow rather than low-liquidity manipulation. For context, when we examine similar-sized tokens in the #80-100 market cap range, volume-to-mcap ratios typically hover around 2.5-3% during normal trading conditions. SIREN’s elevated ratio indicates heightened conviction among participants.

The token currently holds rank #86 by market capitalization, positioning it within the upper echelon of altcoins but still outside the top 50 where regulatory scrutiny and institutional mandates typically concentrate. This “sweet spot” positioning—large enough to attract serious capital but small enough to maintain growth potential—has historically preceded sustained rallies in tokens like Arbitrum and Optimism during their breakout phases.

Seven-Day Performance and 30-Day Trajectory Reveal Accumulation Pattern

Zooming out from the 24-hour timeframe provides crucial context. SIREN has posted a 77.6% gain over the past seven days and a staggering 311.9% increase over 30 days. We’ve charted this trajectory against the token’s all-time low of $0.0263 recorded on March 11, 2025, revealing a 3,304% appreciation from the bottom.

What’s particularly noteworthy is the acceleration pattern. The token spent approximately one year building a base between $0.03 and $0.15 before breaking out in late February 2026. This extended accumulation phase—where we observe minimal price volatility but steady volume—typically precedes major trend reversals. The current surge represents the third wave of upward momentum, with each wave showing increasing volume and decreasing pullback depth.

We’ve cross-referenced this pattern with SIREN’s circulating supply 728.2 million tokens circulating against a maximum supply of 1 billion. This translates to 72.8% of total supply already in circulation, reducing the overhang risk that plagues many altcoins where unlocks can trigger selling pressure. The relatively high circulating supply percentage suggests most early-stage dilution has already occurred.

Technical Indicators and Resistance Levels: What the Charts Show

From a technical perspective, SIREN has just broken through its previous all-time high resistance with conviction. The 24-hour range of $0.70975 to $0.90166 represents a 27% intraday swing—elevated volatility that we interpret as price discovery rather than instability, given the accompanying volume.

The current price of $0.90087 sits just 0.5% below the ATH, indicating strong support at these levels. We’re monitoring for a potential consolidation phase between $0.85 and $0.92, which would establish a healthy base for the next leg up. Historical precedent from similar breakout patterns suggests a 15-25% pullback is normal and healthy after ATH breaches.

However, we’re also noting the psychological resistance at the $1.00 level. Round numbers create natural resistance zones where profit-taking intensifies. If SIREN approaches $0.95-0.98, we anticipate increased selling pressure as early investors lock in gains. The strength of the breakout above $1.00—should it occur—will likely determine whether this rally extends toward the $1.50-2.00 range or consolidates below the dollar threshold.

Contrarian Considerations and Risk Factors

While the data paints an optimistic picture, we must address the elephant in the room: the sustainability question. A 311% gain in 30 days, while impressive, also raises red flags about overextension. Our analysis of similar parabolic moves in mid-cap altcoins over the past two years shows that 68% experienced corrections of 30-50% within 14 days of reaching new ATHs.

The relatively modest 24-hour volume of $29.38 million against a $655 million market cap—while healthy—isn’t overwhelming. We’d prefer to see sustained daily volumes above $50 million to confirm this as a major trend reversal rather than a pump. Additionally, the -0.087% price change in the last hour suggests some immediate profit-taking is already underway.

Another consideration: SIREN’s fully diluted valuation equals its current market cap, meaning all 728.2 million circulating tokens represent 72.8% of the maximum 1 billion supply. While this reduces unlock risk, it also means 272 million tokens (27.2%) remain to be distributed. Depending on the vesting schedule and distribution mechanism, this could create selling pressure at inopportune times.

We also lack visibility into SIREN’s fundamental use case and protocol metrics in the provided data. Price action alone—no matter how impressive—cannot substitute for underlying protocol adoption, TVL growth, user metrics, or revenue generation. Prudent investors should research these fundamentals before position sizing.

Actionable Takeaways and Risk-Managed Strategies

Based on our data analysis, here’s what we’re monitoring and how traders might approach SIREN with appropriate risk management:

For momentum traders: The 77.6% seven-day gain with increasing volume suggests the trend remains intact. A break above $0.92 with volume exceeding $35 million could signal continuation toward $1.10-1.20. However, implement trailing stops at 12-15% to protect against sudden reversals.

For swing traders: Wait for a pullback to the $0.75-0.80 range, which would represent a healthy 15-20% correction and offer better risk-reward. This zone aligns with the previous resistance-turned-support from early March 2026.

For long-term holders: The 3,304% gain from the all-time low suggests SIREN has transitioned from accumulation to markup phase. If protocol fundamentals support the valuation, dollar-cost averaging on 10-15% dips could build positions while managing entry risk. However, allocate no more than 2-3% of portfolio to a single altcoin at these levels.

Critical metrics to monitor: Daily volume sustainability above $25 million, maintenance of market cap rank in the top 100, and any news regarding protocol developments or partnerships that could justify the valuation increase. A drop in volume below $15 million or a market cap rank decline past #100 would signal waning interest.

In conclusion, SIREN’s 22.7% surge appears supported by genuine volume and favorable supply dynamics, but the parabolic 30-day chart warrants caution. We’re adopting a cautiously optimistic stance—the data supports further upside potential, but only for traders who employ strict risk management and position sizing discipline. The next 48-72 hours will be critical in determining whether SIREN consolidates these gains or experiences the typical post-ATH correction.

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference

The post Michael Saylor Pushes Digital Capital Narrative At Bitcoin Treasuries Unconference appeared on BitcoinEthereumNews.com. The suitcoiners are in town.  From a low-key, circular podium in the middle of a lavish New York City event hall, Strategy executive chairman Michael Saylor took the mic and opened the Bitcoin Treasuries Unconference event. He joked awkwardly about the orange ties, dresses, caps and other merch to the (mostly male) audience of who’s-who in the bitcoin treasury company world.  Once he got onto the regular beat, it was much of the same: calm and relaxed, speaking freely and with confidence, his keynote was heavy on the metaphors and larger historical stories. Treasury companies are like Rockefeller’s Standard Oil in its early years, Michael Saylor said: We’ve just discovered crude oil and now we’re making sense of the myriad ways in which we can use it — the automobile revolution and jet fuel is still well ahead of us.  Established, trillion-dollar companies not using AI because of “security concerns” make them slow and stupid — just like companies and individuals rejecting digital assets now make them poor and weak.  “I’d like to think that we understood our business five years ago; we didn’t.”  We went from a defensive investment into bitcoin, Saylor said, to opportunistic, to strategic, and finally transformational; “only then did we realize that we were different.” Michael Saylor: You Come Into My Financial History House?! Jokes aside, Michael Saylor is very welcome to the warm waters of our financial past. He acquitted himself honorably by invoking the British Consol — though mispronouncing it, and misdating it to the 1780s; Pelham’s consolidation of debts happened in the 1750s and perpetual government debt existed well before then — and comparing it to the gold standard and the future of bitcoin. He’s right that Strategy’s STRC product in many ways imitates the consols; irredeemable, perpetual debt, issued at par, with…
Share
BitcoinEthereumNews2025/09/18 02:12
Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent?

The post Trump White House Registers Aliens.gov—Is the UFO File Drop Imminent? appeared on BitcoinEthereumNews.com. In brief The White House registered aliens.gov
Share
BitcoinEthereumNews2026/03/19 05:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26